BSE Code: | NSE Code: | ISIN: | Sector:
Research Report Detail
|Report Date||Call||Price@Call||Target Price
|Current Status||Time Horizon|
|Bank of America Merrill Lynch
Bank of America Merrill Lynch maintains buy on Aurobindo Pharma
Bank of America Merrill Lynch has maintained buy on Aurobindo Pharma for target price of Rs 1,050. It says investor concerns on FDA overdone and correction offers enhanced buying opportunity. It sees multiple growth levers for Aurobindo and US business is in a sweet spot.